Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: December 2011

Uranium Energy Corp (UEC) Completes Acquisition of the Workman Creek Project in Arizona

Uranium Energy is pleased to announce that it has now completed its acquisition of the Workman Creek uranium project, previously announced on November 8, 2011, located in Gila County, Arizona (the “Workman Creek Project”), from Cooper Minerals, Inc. (“Cooper”). President … Continue reading

Posted in Uranium Energy Corp. UEC | Leave a comment

MissionIR Features VistaGen Therapeutics, Inc. (VSTA) in Exclusive Interview with CEO Shawn Singh

MissionIR today announces that its interview with Shawn Singh, the Chief Executive Officer of VistaGen Therapeutics, is now available online. The complete interview can be heard at http://www.vsta.missionir.com/vsta-12-11.mp3. Mr. Singh provided a brief overview of the company, its drug rescue … Continue reading

Posted in VistaGen Therapeutics Inc. VSTA | Leave a comment

ChinaCache International Holding (CCIH) Opens Doors of New North America R&D Center

Today, ChinaCache International Holding, Ltd. announced the opening of its North American-based R&D center, located in Silicon Valley. In addition to providing additional resources for ChinaCache’s North American customer base, the facility will be developing next-gen content-aware network services. ChinaCache … Continue reading

Posted in Small Cap News | Leave a comment

GlobalSCAPE, Inc. (GSB) Strengthens Offerings through Strategic Acquisition of TappIn

GlobalSCAPE Inc., a leading developer of secure information exchange solutions for businesses and consumers, today announced it has completed its acquisition of privately held mobile file sharing innovator TappIn Inc., formerly known as HomePipe Networks Inc. TappIn allows users to … Continue reading

Posted in Small Cap News | Leave a comment

VistaGen Therapeutics Inc. (VSTA) Science Advisory Board Taps Big Pharma Expertise

VistaGen, a biotechnology company applying human pluripotent stem cell technology to drug rescue and cell therapy, is able to take advantage of a science advisory board with a wealth of experience in dealing with the pharmaceutical industry. It’s a critical … Continue reading

Posted in VistaGen Therapeutics Inc. VSTA | Leave a comment

AdCare Health Systems (ADK) Acquires 4 Skilled Nursing Facilities, Fifth on the Horizon

AdCare Health Systems, Inc., a nursing home and assisted living company, today announced it has completed the acquisition of four skilled nursing facilities in Arkansas, and in the next 90 days will close on the purchase of one skilled nursing … Continue reading

Posted in Small Cap News | Leave a comment

Synergy Resources Corp. (SYRG) Secures $15 Million Line of Credit

Synergy Resources Corp. is a domestic oil and natural gas exploration and production company. The company core area of operations is in the Denver-Julesberg Basin, which encompasses Colorado, Wyoming, Kansas and Nebraska. The Wattenberg field in the Basin is the … Continue reading

Posted in Small Cap News | Leave a comment

AdCare Health Systems (ADK) Closes Acquisition of Skilled Nursing and Assisted Living Center in Arkansas

AdCare Health Systems, Inc., a leading nursing home and assisted living company, has closed the previously announced asset purchase of a skilled nursing and assisted living community in Mountain View, Arkansas for $4.2 million. The facilities have an aggregate of … Continue reading

Posted in AdCare Health Systems Inc. ADK | Leave a comment

Rackwise, Inc. (RACK) Flagship Data Center Infrastructure Management Platform to Embed Device-Level Intel Technology under New Agreement

Rackwise, developers of Data Center Infrastructure Management (DCIM) software platform RACKWISE®, reported execution of a key, multi-year software integration and license agreement for RACKWISE with tech sector giant Intel®. The agreement calls for integration of real-time data collection and device … Continue reading

Posted in Small Cap News | Leave a comment

ADVENTRX Pharmaceuticals (ANX) Meets with FDA Regarding Plans for ANX-188 Treatment

Today, ADVENTRX Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing proprietary product candidates, announced that it met with the U.S. Food and Drug Administration (FDA) to review development plans for ANX-188 (purified poloxamer 188). ANX-188 is the company’s first-in-class … Continue reading

Posted in Small Cap News | Leave a comment